RT Journal Article
SR Electronic
T1 Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.05.23288191
DO 10.1101/2023.04.05.23288191
A1 Tripodo, Claudio
A1 Bertolazzi, Giorgio
A1 Cancila, Valeria
A1 Morello, Gaia
A1 Iannitto, Emilio
YR 2023
UL http://medrxiv.org/content/early/2023/04/06/2023.04.05.23288191.abstract
AB We have established a pseudotemporal ordering for the transcriptional signatures of distinct microregions within reactive lymphoid tissues, namely germinal center dark zones (DZ), germinal center light zones (LZ), and peri-follicular areas (Peri). By utilizing this pseudotime trajectory derived from the functional microenvironments of DZ, LZ, and Peri, we have ordered the transcriptomes of Diffuse Large B-cell Lymphoma cases. The apex of the resulting pseudotemporal trajectory, which is characterized by enrichment of molecular programs fronted by TNFR signaling and inhibitory immune checkpoint overexpression, intercepts a discrete peri-follicular biology. This observation is associated with DLBCL cases that are enriched in the Unclassified/type-3 COO category, raising questions about the potential extra-GC microenvironment imprint of this peculiar group of cases. This report offers a thought-provoking perspective on the relationship between transcriptional profiling of functional lymphoid tissue microenvironments and the evolving concept of the cell of origin in Diffuse Large B-cell Lymphomas.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Italian Foundation for Cancer Research (AIRC)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the datasets used in the study are publicly available at the following links:: https://onlinelibrary.wiley.com/doi/full/10.1002/eji.202149746 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32918 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10846 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117556I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript https://onlinelibrary.wiley.com/doi/full/10.1002/eji.202149746 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32918 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10846 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117556